Mars Family’s $36B Kellanova Acquisition Revealedby Mark Eisenberg 15.08.2024Mars Inc's biggest acquisition ever at $36 billion showcases their strategy in private conglomerate expansion.
Beam Therapeutics: Genetic Medicine Pioneerby Lilu Anderson 15.08.2024Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Meiji Yasuda Acquires Allstate’s Voluntary Benefitsby Mark Eisenberg 14.08.2024Japan's Meiji Yasuda buys Allstate's business for $2B to boost global profits by 2027.
Mercury Systems Shares Surge on Q4 Earnings Beatby Mark Eisenberg 14.08.2024Mercury Systems shares rose 10% after Q4 earnings beat expectations with $248.6M in revenue and a $0.23 EPS.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
KULR Technology Group Q2 2024 Financials Releasedby Lilu Anderson 13.08.2024KULR Technology Group reports Q2 2024 financials, showing revenue shifts and strategic advancements.
Legend Biotech’s Q2 2024 Earnings: Growth & Strategyby Lilu Anderson 12.08.2024Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
InspireMD Eyes US Launch Amid Revenue Growthby Mark Eisenberg 11.08.2024InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
CCL Industries Reports Strong Q2 Growthby Mark Eisenberg 11.08.2024CCL Industries sees 12.2% sales rise in Q2 2024, but market uncertainties persist.
Mogo Finance Reports Q2 Growth Focus on Wealth, Paymentsby Mark Eisenberg 11.08.2024Mogo sees 10% revenue growth, strong wealth focus, and positive cash flow in Q2, despite crypto investments not contributing to ...